Publications

• Akira Endo (1933-2024), In Memoriam.
  J Clin Lipidol
  09/14/2024 Authors: Brown WV; Schaefer EJ; Gotto AM
• Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale.
  J Am Geriatr Soc Volume: 71 Page(s): 1701 - 1713
  06/01/2023 Authors: Joseph J; Pajewski NM; Dolor RJ; Sellers MA; Perdue LH; Peeples SR; Henrie AM; Woolard N; Jones WS; Benziger CP
• Serum urate and cardiovascular events in the DCCT/EDIC study.
  Sci Rep Volume: 11 Page(s): 14182
  07/09/2021 Authors: Jenkins AJ; Braffett BH; Basu A; Bebu I; Dagogo-Jack S; Orchard TJ; Wallia A; Lopes-Virella MF; Garvey WT; Lachin JM
• Methods of Calculating Low-Density Lipoprotein Cholesterol Level.
  JAMA Cardiol Volume: 5 Page(s): 502 - 503
  05/01/2020 Authors: Brown WV
• DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes.
  Clin Epigenetics Volume: 12 Page(s): 52
  04/05/2020 Authors: Roshandel D; Chen Z; Canty AJ; Bull SB; Natarajan R; Paterson AD; DCCT/EDIC Research Group
• Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
  J Clin Lipidol Volume: 13 Page(s): 997 - 1007.e8
  01/01/2019 Authors: Toth PP; Bays HE; Brown WV; Catapano AL; Davidson MH; Farnier M; Tomassini JE; Jensen E; Polis AB; Tershakovec AM
• Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.
  Clin Pharmacol Ther Volume: 104 Page(s): 269 - 281
  08/01/2018 Authors: Brown WV
• Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management.
  J Clin Lipidol Volume: 12 Page(s): 254 - 263
  01/01/2018 Authors: Brown WV; Goldberg I; Duell B; Gaudet D
• Roundtable on etiology of familial chylomicronemia syndrome.
  J Clin Lipidol Volume: 12 Page(s): 5 - 11
  01/01/2018 Authors: Brown WV; Gaudet D; Goldberg I; Hegele R
• From the Editor: Using PCSK9 inhibitors in practice
  JOURNAL OF CLINICAL LIPIDOLOGY Volume: 11 Page(s): 843 - 844
  08/01/2017 Authors: Brown WV
• JCL roundtable: Future of the lipid laboratory: Using the laboratory to manage the patient (part 2)
  JOURNAL OF CLINICAL LIPIDOLOGY Volume: 11 Page(s): 846 - 854
  08/01/2017 Authors: Brown WV; Handelsman Y; Martin SS; Morris PB
• Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.
  J Lipid Res Volume: 58 Page(s): 1315 - 1324
  07/01/2017 Authors: Thongtang N; Diffenderfer MR; Ooi EMM; Barrett PHR; Turner SM; Le N-A; Brown WV; Schaefer EJ
• Genetics and Valve Calcification.
  J Am Coll Cardiol Volume: 69 Page(s): 2949 - 2951
  06/20/2017 Authors: Brown WV
• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
  N Engl J Med Volume: 376 Page(s): 1713 - 1722
  05/04/2017 Authors: Sabatine MS; Giugliano RP; Keech AC; Honarpour N; Wiviott SD; Murphy SA; Kuder JF; Wang H; Liu T; Wasserman SM
• JCL roundtable: Managing lipid disorders in patients with HIV.
  J Clin Lipidol Volume: 11 Page(s): 4 - 11
  01/01/2017 Authors: Brown WV; Aberg JA; Aspry KE; Longenecker CT; Myerson M
• From the Editor: New guidelines are coming.
  J Clin Lipidol Volume: 11 Page(s): 1 - 2
  01/01/2017 Authors: Brown WV
• JCL roundtable: Cardiovascular disease risk reduction in menopausal women.
  J Clin Lipidol Volume: 11 Page(s): 316 - 324
  01/01/2017 Authors: Brown WV; Gulati M; Lundberg GP
• From the Editor: Preventing cardiovascular death.
  J Clin Lipidol Volume: 11 Page(s): 313 - 314
  01/01/2017 Authors: Brown WV
• JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1).
  J Clin Lipidol Volume: 11 Page(s): 587 - 595
  01/01/2017 Authors: Brown WV; Handelsman Y; Martin SS; Morris PB
• From the Editor: The Journal of Clinical Lipidology-2007 to 2017.
  J Clin Lipidol Volume: 11 Page(s): 581 - 585
  01/01/2017 Authors: Brown WV
• JCL roundtable: Future of the lipid laboratory: Using the laboratory to manage the patient (part 2).
  J Clin Lipidol Volume: 11 Page(s): 846 - 854
  01/01/2017 Authors: Brown WV; Handelsman Y; Martin SS; Morris PB
• From the Editor: Using PCSK9 inhibitors in practice.
  J Clin Lipidol Volume: 11 Page(s): 843 - 844
  01/01/2017 Authors: Brown WV
• Genetic effects on efficacy of lipid-lowering drugs.
  J Clin Lipidol Volume: 11 Page(s): 1112 - 1117
  01/01/2017 Authors: Brown WV; Brown AS; Ference BA; Toth PP; Underberg JA
• What is sufficient drug therapy for lipoprotein elevations?
  J Clin Lipidol Volume: 11 Page(s): 1300 - 1308
  01/01/2017 Authors: Brown WV; Brown AS; Toth PP; Underberg J
• Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.
  J Urol Volume: 196 Page(s): 1129 - 1135
  10/01/2016 Authors: Lenherr SM; Clemens JQ; Braffett BH; Cleary PA; Dunn RL; Hotaling JM; Jacobson AM; Kim C; Herman W; Brown JS
• Response to Sahoo et al.
  Genet Med Volume: 18 Page(s): 277
  03/01/2016 Authors: Yatsenko SA; Peters DG; Rajkovic A
• JCL roundtable: PCSK9 inhibitors in clinical practice.
  J Clin Lipidol Volume: 10 Page(s): 5 - 14
  01/01/2016 Authors: Brown WV; Moriarty PM; McKenney JM
• National Lipid Association Annual Summary of Clinical Lipidology 2016.
  J Clin Lipidol Volume: 10 Page(s): S1 - 43
  01/01/2016 Authors: Bays HE; Jones PH; Orringer CE; Brown WV; Jacobson TA
• From the Editor: New drugs, old lessons.
  J Clin Lipidol Volume: 10 Page(s): 1 - 2
  01/01/2016 Authors: Brown WV
• JCL Roundtable: Should we treat elevations in Lp(a)?
  J Clin Lipidol Volume: 10 Page(s): 215 - 224
  01/01/2016 Authors: Brown WV; Moriarty PM; Remaley AT; Tsimikas S
• From the Editor: New and good are not the same!
  J Clin Lipidol Volume: 10 Page(s): 213
  01/01/2016 Authors: Brown WV
• JCL roundtable: Lessons from genetic variants altering lipoprotein metabolism.
  J Clin Lipidol Volume: 10 Page(s): 448 - 457
  01/01/2016 Authors: Brown WV; Ference BA; Kathiresan S
• From the Editor: National Lipid Association, the annual scientific sessions, triglycerides, and apolipoprotein-CIII.
  J Clin Lipidol Volume: 10 Page(s): 445 - 446
  01/01/2016 Authors: Brown WV
• Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study.
  PLoS One Volume: 11 Page(s): e0159958
  01/01/2016 Authors: Darabian S; Backlund J-YC; Cleary PA; Sheidaee N; Bebu I; Lachin JM; Budoff MJ; DCCT/EDIC Research Group
• JCL roundtable: Diagnosis and clinical management of lipodystrophy.
  J Clin Lipidol Volume: 10 Page(s): 728 - 736
  01/01/2016 Authors: Brown WV; Garg A; Gorden P; Shamburek R
• From the Editor: Growth of the Journal of Clinical Lipidology in volume and impact.
  J Clin Lipidol Volume: 10 Page(s): 725
  01/01/2016 Authors: Brown WV
• JCL roundtable: Managing lipid disorders in young women.
  J Clin Lipidol Volume: 10 Page(s): 1058 - 1066
  01/01/2016 Authors: Brown WV; Morris PB; Wild RA
• From the Editor: What should be our target of treatment?
  J Clin Lipidol Volume: 10 Page(s): 1055 - 1056
  01/01/2016 Authors: Brown WV
• JCL roundtable: Risk evaluation and mitigation strategy.
  J Clin Lipidol Volume: 10 Page(s): 1288 - 1296
  01/01/2016 Authors: Brown WV; Bramlet DA; Ross JL; Underberg JA
• From the Editor: Tying clinical lipidology to its roots in academia.
  J Clin Lipidol Volume: 10 Page(s): 1283 - 1286
  01/01/2016 Authors: Brown WV
• Inverse relationship between high-density lipoprotein cholesterol raising and high-sensitivity C-reactive protein reduction in older patients treated with lipid-lowering therapy.
  J Clin Lipidol Volume: 10 Page(s): 116 - 123
  01/01/2016 Authors: Brown WV; Foody JM; Zieve FJ; Tomassini JE; Shah A; Tershakovec AM
• Cholesterol in Remnant-Lipoproteins as Measured by Different Methods
  Volume: 66 Page(s): C228 - C229
  10/20/2015 Authors: Toth PP; Bays HE; Brown WV; Tomassini JE; Wang C; Polis AB; Tershakovec AM
• CHOLESTEROL IN REMNANT-LIPOPROTEINS AS MEASURED BY DIFFERENT METHODS
  Volume: 241 Page(s): E39 - E39
  07/01/2015 Authors: Toth PP; Bays HE; Brown WV; Tomassini JE; Wang Y; Polis AB; Tershakovec AM
• Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
  Eur J Prev Cardiol Volume: 22 Page(s): 849 - 854
  07/01/2015 Authors: Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M
• Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.
  Lipids Volume: 50 Page(s): 447 - 458
  05/01/2015 Authors: Le N-A; Diffenderfer MR; Thongtang N; Ooi EMM; Barrett PHR; Horvath KV; Dolnikowski GG; Asztalos BF; Schaefer EJ; Brown WV
• From the editor: managing your manuscripts.
  J Clin Lipidol Volume: 9 Page(s): 115 - 116
  01/01/2015 Authors: Kerr A; Brown WV
• From the Editor: Is a goal a target?
  J Clin Lipidol Volume: 9 Page(s): 727 - 730
  01/01/2015 Authors: Brown WV
• JCL roundtable: Apolipoproteins as causative elements in vascular disease.
  J Clin Lipidol Volume: 9 Page(s): 733 - 740
  01/01/2015 Authors: Brown WV; Sacks FM; Sniderman AD
• National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
  J Clin Lipidol Volume: 9 Page(s): 129 - 169
  01/01/2015 Authors: Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA
• JCL Roundtable: is inflammation a future target in preventing arteriosclerotic cardiovascular disease.
  J Clin Lipidol Volume: 9 Page(s): 119 - 128
  01/01/2015 Authors: Brown WV; Remaley AT; Ridker PM
• From the Editor: Cytokines and HDL cholesterol. Foreword.
  J Clin Lipidol Volume: 9 Page(s): 1
  01/01/2015 Authors: Brown WV
• JCL roundtable: fast food and the American diet.
  J Clin Lipidol Volume: 9 Page(s): 3 - 10
  01/01/2015 Authors: Brown WV; Carson JAS; Johnson RK; Kris-Etherton P
• From the Editor: The physician as a personal teacher and guide.
  J Clin Lipidol Volume: 9 Page(s): 619 - 621
  01/01/2015 Authors: Brown WV
• JCL Roundtable: Gender differences in reduction of CVD in response to lipid-lowering drugs.
  J Clin Lipidol Volume: 9 Page(s): 624 - 633
  01/01/2015 Authors: Brown WV; Mackey RH; Orringer CE; Pearson TA
• JCL Roundtable: Gender differences in risk reduction with lifestyle changes.
  J Clin Lipidol Volume: 9 Page(s): 486 - 495
  01/01/2015 Authors: Brown WV; Bays HE; La Forge R; Sikand G
• From the Editor: The Akira Endo Award. Foreword.
  J Clin Lipidol Volume: 9 Page(s): 479 - 483
  01/01/2015 Authors: Brown WV
• Clinical lipidology: A subspecialty whose time has come.
  J Clin Lipidol Volume: 9 Page(s): 634 - 639
  01/01/2015 Authors: Orringer CE; Bays HE; Brown WV
• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
  J Clin Lipidol Volume: 9 Page(s): S1 - 122.e1
  01/01/2015 Authors: Jacobson TA; Maki KC; Orringer CE; Jones PH; Kris-Etherton P; Sikand G; La Forge R; Daniels SR; Wilson DP; Morris PB
• Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
  PLoS One Volume: 10 Page(s): e0141286
  01/01/2015 Authors: Lorenzi GM; Braffett BH; Arends VL; Danis RP; Diminick L; Klumpp KA; Morrison AD; Soliman EZ; Steffes MW; Cleary PA
• JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function.
  J Clin Lipidol Volume: 9 Page(s): 274 - 280
  01/01/2015 Authors: Brown WV; Goldberg IJ; Young SG
• From the Editor: Clinical lipidology is growing in its scientific strength and clinical relevance.
  J Clin Lipidol Volume: 9 Page(s): 271 - 272
  01/01/2015 Authors: Brown WV
• Association of Clinical Variables and Calf Arterial Compliance in Veterans with Psychiatric Diagnosis
  Volume: 75 Page(s): 386S - 386S
  05/01/2014 Authors: Koola MM; Sorkin JD; Brown WV; Cuthbert B; Hollis J; Duncan EJ
• Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
  Int J Cardiol Volume: 171 Page(s): 309 - 325
  02/15/2014 Authors: Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M
• Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
  JAMA Volume: 311 Page(s): 252 - 262
  01/15/2014 Authors: Nicholls SJ; Kastelein JJP; Schwartz GG; Bash D; Rosenson RS; Cavender MA; Brennan DM; Koenig W; Jukema JW; Nambi V
• JCL roundtable: drug treatment of severe forms of familial hypercholesterolemia.
  J Clin Lipidol Volume: 8 Page(s): 10 - 17
  01/01/2014 Authors: Brown WV; Rader DJ; Goldberg AC
• From the editor: an interview with Dr. Scott Grundy.
  J Clin Lipidol Volume: 8 Page(s): 1 - 8
  01/01/2014 Authors: Grundy S; Brown WV
• JCL Roundtable: health information technology in the management of lipoprotein disorders.
  J Clin Lipidol Volume: 8 Page(s): 137 - 147
  01/01/2014 Authors: Brown WV; Brown AS; Aspry KE; Ito MK
• Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation.
  J Clin Lipidol Volume: 8 Page(s): 148 - 172
  01/01/2014 Authors: Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M
• Foreword. From the editor.
  J Clin Lipidol Volume: 8 Page(s): 135
  01/01/2014 Authors: Brown WV
• JCL roundtable: Clinical management of individuals with obesity.
  J Clin Lipidol Volume: 8 Page(s): 237 - 248
  01/01/2014 Authors: Brown WV; Bays H; Bray GA
• Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summary.
  J Atheroscler Thromb Volume: 21 Page(s): 368 - 374
  01/01/2014 Authors: Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M
• An assessment by the Statin Diabetes Safety Task Force: 2014 update.
  J Clin Lipidol Volume: 8 Page(s): S17 - S29
  01/01/2014 Authors: Maki KC; Ridker PM; Brown WV; Grundy SM; Sattar N; The Diabetes Subpanel of the National Lipid Association Expert Panel
• From the editor: the national meeting of the NLA.
  J Clin Lipidol Volume: 8 Page(s): 235
  01/01/2014 Authors: Brown WV
• JCL roundtable: HDL in the primary care setting.
  J Clin Lipidol Volume: 8 Page(s): 364 - 372
  01/01/2014 Authors: Brown WV; Ansell BJ; Mackey RH; Toth PP
• From the editor: The art of prevention.
  J Clin Lipidol Volume: 8 Page(s): 359 - 362
  01/01/2014 Authors: Brown WV
• National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.
  J Clin Lipidol Volume: 8 Page(s): 473 - 488
  01/01/2014 Authors: Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA
• JCL Roundtable: enzyme replacement therapy for lipid storage disorders.
  J Clin Lipidol Volume: 8 Page(s): 463 - 472
  01/01/2014 Authors: Brown WV; Desnick RJ; Grabowski GA
• From the editor: clinical lipidology and the pediatrician.
  J Clin Lipidol Volume: 8 Page(s): 461
  01/01/2014 Authors: Brown WV
• National Lipid Association Annual Summary of Clinical Lipidology 2015.
  J Clin Lipidol Volume: 8 Page(s): S1 - 36
  01/01/2014 Authors: Bays HE; Jones PH; Brown WV; Jacobson TA; National Lipid Association
• JCL roundtable: lipid-lowering drugs in those older than 75 years of age.
  J Clin Lipidol Volume: 8 Page(s): 533 - 541
  01/01/2014 Authors: Brown WV; Bittner VA; McKenney JM; Ziajka PE
• From the editor: drugs, genes, and lipoproteins.
  J Clin Lipidol Volume: 8 Page(s): 529 - 530
  01/01/2014 Authors: Brown WV
• Effect of ABT-335 (fenofibric acid) on meal-induced oxidative stress in patients with metabolic syndrome.
  Atherosclerosis Volume: 231 Page(s): 268 - 273
  12/01/2013 Authors: Le N-A; Farkas-Epperson M; Sweeney ME; Wilson PWF; Virgil Brown W
• From the Editor: The future of managing lipoprotein disorders.
  J Clin Lipidol Volume: 7 Page(s): 535 - 538
  11/01/2013 Authors: Brown WV
• JCL Roundtable: diagnosis of severe familial hypercholesterolemia.
  J Clin Lipidol Volume: 7 Page(s): 540 - 545
  01/01/2013 Authors: Brown WV; Rader DJ; Kane J
• Screening and management of cardiovascular risk factors in children.
  J Clin Lipidol Volume: 7 Page(s): 390 - 398
  01/01/2013 Authors: Brown WV; McNeal CJ; Gidding SS
• Achieving adherence to lipid-lowering regimens.
  J Clin Lipidol Volume: 7 Page(s): 4 - 13
  01/01/2013 Authors: Brown WV; Jacobson TA; Braun LT
• From the editor: selling the benefit of drug therapy.
  J Clin Lipidol Volume: 7 Page(s): 1 - 2
  01/01/2013 Authors: Brown WV
• From the editor: Learning from defects.
  J Clin Lipidol Volume: 7 Page(s): 91 - 92
  01/01/2013 Authors: Brown WV
• From the editor: What is obesity?
  J Clin Lipidol Volume: 7 Page(s): 289 - 290
  01/01/2013 Authors: Brown WV
• Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.
  J Clin Lipidol Volume: 7 Page(s): 304 - 383
  01/01/2013 Authors: Bays HE; Toth PP; Kris-Etherton PM; Abate N; Aronne LJ; Brown WV; Gonzalez-Campoy JM; Jones SR; Kumar R; La Forge R
• From the editor: The importance of children. Foreword.
  J Clin Lipidol Volume: 7 Page(s): 387 - 388
  01/01/2013 Authors: Brown WV
• Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
  N Engl J Med Volume: 367 Page(s): 2482 - 2494
  12/27/2012 Authors: EVOLVE Trial Investigators; Chertow GM; Block GA; Correa-Rotter R; Dreke TB; Floege J; Goodman WG; Herzog CA; Kubo Y; London GM
• Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
  Circ Cardiovasc Qual Outcomes Volume: 5 Page(s): e51 - e60
  09/01/2012 Authors: Turan TN; Lynn MJ; Nizam A; Lane B; Egan BM; Le N-A; Lopes-Virella MF; Hermayer KL; Benavente O; White CL
• Reduced arterial compliance in patients with psychiatric diagnoses.
  Schizophr Res Volume: 137 Page(s): 251 - 253
  05/01/2012 Authors: Koola MM; Brown WV; Qualls C; Cuthbert B; Hollis JP; Kelly DL; Le N-A; Raines J; Duncan EJ
• Medications that lower low-density lipoprotein (LDL) cholesterol and nonhigh-density lipoprotein (non-HDL) cholesterol.
  J Clin Lipidol Volume: 6 Page(s): 95
  01/01/2012 Authors: Brown WV
• The use of lipopheresis in the practice of clinical lipidology.
  J Clin Lipidol Volume: 6 Page(s): 98 - 104
  01/01/2012 Authors: Brown WV; Brook R; Hemphill LC; Moriarty PM
• Clinical use of genetic typing in human lipid disorders.
  J Clin Lipidol Volume: 6 Page(s): 199 - 207
  01/01/2012 Authors: Brown WV; Breslow J; Ballantyne C
• From the editor: what are the important questions for clinical trials?
  J Clin Lipidol Volume: 6 Page(s): 299 - 300
  01/01/2012 Authors: Brown WV
• From the editor: the enigma of hypertriglyceridemia.
  J Clin Lipidol Volume: 6 Page(s): 393 - 394
  01/01/2012 Authors: Brown WV
• Severe hypertriglyceridemia.
  J Clin Lipidol Volume: 6 Page(s): 397 - 408
  01/01/2012 Authors: Brown WV; Brunzell JD; Eckel RH; Stone NJ
• From the editor.
  J Clin Lipidol Volume: 6 Page(s): 481 - 482
  01/01/2012 Authors: Brown WV
• Planning a clinical trial.
  J Clin Lipidol Volume: 6 Page(s): 484 - 495
  01/01/2012 Authors: Brown WV; Bays HE; Maki KC; Wild RA
• Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
  Diabet Med Volume: 28 Page(s): 1088 - 1095
  09/01/2011 Authors: Beisswenger PJ; Brown WV; Ceriello A; Le NA; Goldberg RB; Cooke JP; Robbins DC; Sarwat S; Yuan H; Jones CA
• RELATIONSHIPS BETWEEN HSCRP REDUCTION AND LDL-C, NON-HDL-C, APOB AND HDL-C IN HYPERLIPIDEMIC PATIENTS TREATED WITH EZETIMIBE/SIMVASTATIN plus EXTENDED-RELEASE NIACIN
  Volume: 12 Page(s): 14 - 14
  06/01/2011 Authors: Brown WV; Fazio S; Guyton JR; Dong Q; Tomassini JE; Shah A; Tershakovec AM
• Apolipoprotein CIII: 42 years old and even more interesting.
  Arterioscler Thromb Vasc Biol Volume: 31 Page(s): 471 - 473
  03/01/2011 Authors: Ginsberg HN; Brown WV
• Reducing vascular disease risk in the type 2 diabetic patient.
  J Clin Lipidol Volume: 5 Page(s): 3 - 11
  01/01/2011 Authors: Brown WV; Goldberg RB; Lopes-Virella M; Reaven P
• Current approaches to arteriosclerosis.
  J Clin Lipidol Volume: 5 Page(s): 61 - 63
  01/01/2011 Authors: Brown WV
• Drugs in development for management of lipoprotein disorders.
  J Clin Lipidol Volume: 5 Page(s): 66 - 75
  01/01/2011 Authors: Brown WV; Bays H; Davidson M; Goldberg A
• From the editor. Foreword.
  J Clin Lipidol Volume: 5 Page(s): 121
  01/01/2011 Authors: Brown WV
• From the editor.
  J Clin Lipidol Volume: 5 Page(s): 247 - 248
  01/01/2011 Authors: Brown WV
• Assessment and management of vascular disease risk in patients with chronic kidney disease.
  J Clin Lipidol Volume: 5 Page(s): 251 - 260
  01/01/2011 Authors: Brown WV; Bakris G; Lerma E; Chertow G
• Framingham Heart Study.
  J Clin Lipidol Volume: 5 Page(s): 335
  01/01/2011 Authors: Brown WV
• Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
  J Clin Lipidol Volume: 5 Page(s): 338 - 367
  01/01/2011 Authors: Davidson MH; Ballantyne CM; Jacobson TA; Bittner VA; Braun LT; Brown AS; Brown WV; Cromwell WC; Goldberg RB; McKenney JM
• From the editor.
  J Clin Lipidol Volume: 5 Page(s): 421
  01/01/2011 Authors: Brown WV
• Using omega-3 fatty acids in the practice of clinical lipidology.
  J Clin Lipidol Volume: 5 Page(s): 424 - 433
  01/01/2011 Authors: Brown WV; Bays H; Harris W; Miller M
• Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults 65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
  Am J Cardiol Volume: 106 Page(s): 1255 - 1263
  11/01/2010 Authors: Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
• INVERSE RELATIONSHIP BETWEEN HDL-C RAISING AND HSCRP REDUCTION IN OLDER PATIENTS TREATED WITH LIPID-LOWERING THERAPY IN THE VYTELD STUDY
  Volume: 11 Page(s): 69 - 70
  06/10/2010 Authors: Brown W; Foody J; Zieve F; Jones-Burton C; Dong Q; Tomassini J; Shah A; Tershakovec A
• SAFETY AND EFFICACY OF EZETIMIBE/SIMVASTATIN COMBINATION VERSUS ATORVASTATIN IN PATIENTS 65 YEARS OF AGE AND OLDER
  Volume: 11 Page(s): 75 - 76
  06/10/2010 Authors: Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
• HDL as a treatment target.
  J Clin Lipidol Volume: 4 Page(s): 5 - 16
  01/01/2010 Authors: Brown WV; Brewer HB; Rader DJ; Schaefer EJ
• The disparity between the very strong performance of high-density lipoprotein (HDL) cholesterol as a risk factor and the very weak effects. Foreword.
  J Clin Lipidol Volume: 4 Page(s): 1
  01/01/2010 Authors: Brown WV
• Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women.
  J Clin Lipidol Volume: 4 Page(s): 324 - 334
  01/01/2010 Authors: Brown WV; Wenger N; Bittner V; Brinton E
• The use of lipid-lowering drugs in children.
  J Clin Lipidol Volume: 4 Page(s): 449 - 461
  01/01/2010 Authors: Brown WV; Wilson DP; Freemark M; Kwiterovich PO
• Publications from two symposia of the National Lipid Association (NLA) Annual Scientific Sessions held May 14 to 16, 2010 in Chicago. Foreword.
  J Clin Lipidol Volume: 4 Page(s): 321 - 322
  01/01/2010 Authors: Brown WV
• Management of Lp(a).
  J Clin Lipidol Volume: 4 Page(s): 240 - 247
  01/01/2010 Authors: Brown WV; Ballantyne CM; Jones PH; Marcovina S
• Inflammatory markers and treatment of elevated LDL-C. Foreword.
  J Clin Lipidol Volume: 4 Page(s): 237
  01/01/2010 Authors: Brown WV
• Should we use apoB for risk assessment and as a target for treatment?
  J Clin Lipidol Volume: 4 Page(s): 144 - 151
  01/01/2010 Authors: Brown WV; Myers GL; Sniderman AD; Stein E
• Estimating risk and setting targets for treatment in the national effort to reduce cardiovascular diseases. Foreword.
  J Clin Lipidol Volume: 4 Page(s): 139 - 141
  01/01/2010 Authors: Brown WV
• Risk of vascular disease development and recurrence. Foreword.
  J Clin Lipidol Volume: 4 Page(s): 77 - 78
  01/01/2010 Authors: Brown WV
• Using exercise to reduce risk.
  J Clin Lipidol Volume: 3 Page(s): 360 - 367
  12/01/2009 Authors: Brown WV; Fletcher GF; Wilson PW
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 3 Page(s): 357
  12/01/2009 Authors: Brown WV
• Discussion on dietary fat.
  J Clin Lipidol Volume: 3 Page(s): 303 - 314
  10/01/2009 Authors: Brown WV; Karmally W; Kris-Etherton P; Rudel LR
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 3 Page(s): 299 - 300
  10/01/2009 Authors: Brown WV
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 3 Page(s): 241
  08/01/2009 Authors: Brown WV
• Appropriate use of noninvasive vascular measures in the prevention of arterial disease.
  J Clin Lipidol Volume: 3 Page(s): 250 - 261
  08/01/2009 Authors: Brown WV; Brown AS; Raggi P; Sperling LS
• RESULTS OF THE LIPID RESEARCH CLINICS PRIMARY PREVENTION TRIAL
  Volume: 10
  06/01/2009 Authors: Brown W
• The use of niacin.
  J Clin Lipidol Volume: 3 Page(s): 65 - 69
  04/01/2009 Authors: Brown WV; Goldberg AC; Guyton JR; Knopp RH
• From the editor.
  J Clin Lipidol Volume: 3 Page(s): 61 - 62
  04/01/2009 Authors: Brown WV
• Obesity: why be concerned?
  Am J Med Volume: 122 Page(s): S4 - 11
  04/01/2009 Authors: Brown WV; Fujioka K; Wilson PWF; Woodworth KA
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 3 Page(s): 1
  02/01/2009 Authors: Brown WV
• Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection.
  Am J Cardiol Volume: 102 Page(s): 10L - 13L
  12/22/2008 Authors: Brown WV
• From the Editor-in-chief.
  J Clin Lipidol Volume: 2 Page(s): 403
  12/01/2008 Authors: Brown WV
• Safety of statins.
  Curr Opin Lipidol Volume: 19 Page(s): 558 - 562
  12/01/2008 Authors: Brown WV
• The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
  Am J Cardiol Volume: 102 Page(s): 1K - 34K
  11/17/2008 Authors: Fruchart J-C; Sacks F; Hermans MP; Assmann G; Brown WV; Ceska R; Chapman MJ; Dodson PM; Fioretto P; Ginsberg HN
• The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
  Diab Vasc Dis Res Volume: 5 Page(s): 319 - 335
  11/01/2008 Authors: Fruchart J-C; Sacks FM; Hermans MP; Assmann G; Brown WV; Ceska R; Chapman MJ; Dodson PM; Fioretto P; Ginsberg HN
• Optimal management of lipids in diabetes and metabolic syndrome.
  J Clin Lipidol Volume: 2 Page(s): 335 - 342
  10/01/2008 Authors: Brown WV; Clark L; Falko JM; Guyton JR; Rees TJ; Schonfeld G; Lopes-Virella MF
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 2 Page(s): 311
  10/01/2008 Authors: Brown WV
• Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress.
  Clin Biochem Volume: 41 Page(s): 1250 - 1254
  10/01/2008 Authors: Garelnabi MO; Brown WV; Le N-A
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 2 Page(s): 233
  08/01/2008 Authors: Brown WV
• Enhanced hype.
  Am J Cardiol Volume: 102 Page(s): 368 - 369
  08/01/2008 Authors: Harrison DG; Brown WV; Raggi P
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 2 Page(s): 113
  06/01/2008 Authors: Brown WV
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 2 Page(s): 67 - 68
  04/01/2008 Authors: Brown WV
• After a mixed hyperlipidic meal, postprandial and non-insulin postprandial hyperglycemia leads to an increase of inflammatory markers and nitro-oxidant stress in patients with type 2 diabetes
  Volume: 34 Page(s): A82 - A82
  03/01/2008 Authors: Pechtner V; Ceriello A; Brown WV; Le NA; Goldberg RB; Beisswenger PJ; Cooke J; Robbins DC; Moses RG; Jones CA
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 2 Page(s): 1
  02/01/2008 Authors: Brown WV
• Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive protein.
  J Clin Lipidol Volume: 1 Page(s): 593 - 598
  12/01/2007 Authors: Harris MT; Davis WW; Le N-A; Eggleston B; Austin GE; Moussa M; Brown WV
• Cardiovascular disease in obesity: A review of related risk factors and risk-reduction strategies.
  J Clin Lipidol Volume: 1 Page(s): 575 - 582
  12/01/2007 Authors: Aronne LJ; Brown WV; Isoldi KK
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 1 Page(s): 561
  12/01/2007 Authors: Brown WV
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 1 Page(s): 301
  10/01/2007 Authors: Brown WV
• After a high-fat mixed meal, postprandial hyperglycaemia, but not postprandial insulin, impacts postprandial increases in inflammatory markers and nitrosative stress in patients with type 2 diabetes
  Volume: 50 Page(s): S500 - S500
  09/01/2007 Authors: Ceriello A; Brown WV; Le NA; Goldberg RB; Beisswenger PJ; Cooke J; Robbins DC; Moses RG; Yuan HB; Sarwat S
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 1 Page(s): 225 - 226
  08/01/2007 Authors: Brown WV
• Increased meal-induced oxidative stress in HIV-infected patients
  Volume: 27 Page(s): E99 - E99
  06/01/2007 Authors: Walter MF; Folch E; Mehta A; del Rio C; Rimland D; Brown WV; Le N-A
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 1 Page(s): 97 - 99
  05/01/2007 Authors: Brown WV
• Expert commentary: the safety of fibrates in lipid-lowering therapy.
  Am J Cardiol Volume: 99 Page(s): 19C - 21C
  03/19/2007 Authors: Brown WV
• From the Editor-in-Chief.
  J Clin Lipidol Volume: 1 Page(s): 1 - 2
  03/01/2007 Authors: Brown WV
• High-density lipoprotein and transport of cholesterol and triglyceride in blood.
  J Clin Lipidol Volume: 1 Page(s): 7 - 19
  03/01/2007 Authors: Brown WV
• Acute Changes in oxidative and inflammatory markers with LDL apheresis
  Volume: 114 Page(s): 111 - 111
  10/31/2006 Authors: Le NA; Dutton J-A; Moriarty P; Brown WV
• A new approach to apolipoprotein profile analysis for clinical studies
  Volume: 5 Page(s): S313 - S313
  10/01/2006 Authors: Breyer E; Koticha K; Brown WV; Robinson M
• Different definitions of the metabolic syndrome and risk for recurrent cardiovascular disease.
  Nat Clin Pract Endocrinol Metab Volume: 2 Page(s): 492 - 493
  09/01/2006 Authors: Brown WV
• Postprandial increase in hs-CRP in patients with type 2 diabetes (T2D): comparison of lispro mid mixture (MM) plus metformin (Met) with glargine (G) plus met
  Volume: 49 Page(s): 604 - 605
  09/01/2006 Authors: Tan MH; Le N-A; Goldberg RB; Brown WV; Ceriello A; Beisswenger PJ; Sarwat S; Jones CA; Milicevic Z; Robbins DC
• Antiretroviral therapy in HIV-positive women is associated with increased apolipoproteins and total cholesterol.
  J Acquir Immune Defic Syndr Volume: 42 Page(s): 307 - 313
  07/01/2006 Authors: Rimland D; Guest JL; Hernndez-Ramos I; Del Rio C; Le NA; Brown WV
• The Metabolic Syndrome: A disease or a method to identify high risk patients?
  Volume: 7 Page(s): 2 - 3
  06/01/2006 Authors: Brown WV
• Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
  HIV Med Volume: 6 Page(s): 326 - 333
  09/01/2005 Authors: Rimland D; Guest JL; Hernndez I; Del Rio C; Le NA; Brown WV
• Usefulness of arterial compliance in the thigh in predicting exercise capacity in individuals without coronary heart disease.
  Am J Cardiol Volume: 96 Page(s): 306 - 310
  07/15/2005 Authors: Willens HJ; Chirinos JA; Brown WV; Davis WW; Herrington DM; Mosca L; Homma S; Moussa M; Walker G; Raines JK
• Vesicle affinity capillary electrophoresis: a model system for the study of protein-lipid and drug-protein interactions
  Volume: 272 Page(s): 234 - 234
  07/01/2005 Authors: Breyer EDG; Koticha K; Jia Y; Brown WV; Strasters J
• Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men.
  Am J Cardiol Volume: 95 Page(s): 1049 - 1054
  05/01/2005 Authors: Le N-A; Brown WV; Davis WW; Herrington DM; Mosca L; Homma S; Eggleston B; Willens HJ; Raines JK
• Triglycerides are strongly related to vascular stiffness in healthy women
  Volume: 111 Page(s): E53 - E53
  02/01/2005 Authors: Davis WW; Le NA; Brown WV; Herrington D; Homma S; Mosca L; Eggleston B; Raines J
• Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
  J Diabetes Complications Volume: 19 Page(s): 18 - 25
  01/01/2005 Authors: Klein RL; McHenry MB; Lok KH; Hunter SJ; Le N-A; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV
• The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?
  Am J Cardiol Volume: 94 Page(s): 16F - 21F
  11/04/2004 Authors: McKenney JM; Brown WV; Cohen JD; Cahill E
• Understanding physician and consumer attitudes concerning cholesterol management: results from the National Lipid Association surveys.
  Am J Cardiol Volume: 94 Page(s): 9F - 15F
  11/04/2004 Authors: Pasternak RC; McKenney JM; Brown WV; Cahill E; Cohen JD
• Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
  Metabolism Volume: 53 Page(s): 1296 - 1304
  10/01/2004 Authors: Klein RL; McHenry MB; Lok KH; Hunter SJ; Le N-A; Jenkins AJ; Zheng D; Semler AJ; Brown WV; Lyons TJ
• Clinical Chemistry journal has contributed to progress in lipid and lipoprotein testing for fifty years.
  Clin Chem Volume: 50 Page(s): 1861 - 1870
  10/01/2004 Authors: Rifai N; Cooper GR; Brown WV; Friedewald W; Havel RJ; Myers GL; Warnick GR
• Relationship between arterial stiffness and subclinical aortic atherosclerosis.
  Circulation Volume: 110 Page(s): 432 - 437
  07/27/2004 Authors: Herrington DM; Brown WV; Mosca L; Davis W; Eggleston B; Hundley WG; Raines J
• Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease.
  Am J Cardiol Volume: 93 Page(s): 881 - 885
  04/01/2004 Authors: Gradek WQ; Harris MT; Yahia N; Davis WW; Le N-A; Brown WV
• Metabolic syndrome and risk of stroke.
  Clin Cornerstone Volume: 6 Suppl 3 Page(s): S30 - S34
  01/01/2004 Authors: Brown WV
• Simvastatin improved arterial compliance in high-risk patients.
  Vasc Endovascular Surg Volume: 38 Page(s): 519 - 523
  01/01/2004 Authors: Saliashvili G; Davis WW; Harris MT; Le N-A; Brown WV
• National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statintherapy, and pharmacists' services.
  J Am Pharm Assoc (2003) Volume: 44 Page(s): 562 - 568
  01/01/2004 Authors: McKenney JM; Bradberry JC; Talbert RL; Cahill E; Brown WV
• Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial--Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm.
  Curr Opin Lipidol Volume: 14 Page(s): 593 - 597
  12/01/2003 Authors: Brown WV; Moussa M
• Study of lipid and apolipoprotein binding interactions using vesicle affinity capillary electrophoresis.
  Anal Chem Volume: 75 Page(s): 5160 - 5169
  10/01/2003 Authors: Breyer ED; Howard S; Raje N; Allison S; Apkarian R; Brown WV; Strasters JK
• Arterial compliance adds to conventional risk factors for prediction of angiographic coronary artery disease.
  Am Heart J Volume: 146 Page(s): 662 - 667
  10/01/2003 Authors: Herrington DM; Kesler K; Reiber JHC; Davis W; Brown WV; Helms R; Mallon SM; Raines J
• Implications of the heart protection study for reducing coronary events in high-risk patients.
  Curr Atheroscler Rep Volume: 5 Page(s): 358 - 363
  09/01/2003 Authors: Brown WV; Davis W; Harris M
• Cholesterol absorption inhibitors: defining new options in lipid management.
  Clin Cardiol Volume: 26 Page(s): 259 - 264
  06/01/2003 Authors: Brown WV
• Drugs of today - Ezetimibe
  DRUGS OF TODAY Volume: 39 Page(s): 229 - 247
  04/01/2003 Authors: Harris M; Davis W; Brown WV
• Reaching goal: conquering the treatment gaps in dyslipidemia management.
  Clin Cardiol Volume: 26 Page(s): III1 - III2
  04/01/2003 Authors: Brown WV
• Benefits of statin therapy in patients with special risks: coronary bypass surgery, stable coronary disease, and acute coronary syndromes.
  Clin Cardiol Volume: 26 Page(s): III13 - III18
  04/01/2003 Authors: Brown WV
• Ezetimibe.
  Drugs Today (Barc) Volume: 39 Page(s): 229 - 247
  04/01/2003 Authors: Harris M; Davis W; Brown WV
• Correlation of peripheral arterial compliance and framingham coronary heart disease risk evaluation
  Volume: 41 Page(s): 262A - 262A
  03/19/2003 Authors: Davis WW; Brown WV; Herrington D; Mosca L; Wallace D; Willens H; Raines JK
• Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.
  Am J Cardiol Volume: 91 Page(s): 3C - 10C
  03/06/2003 Authors: Blasetto JW; Stein EA; Brown WV; Chitra R; Raza A
• Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion
  AMERICAN JOURNAL OF CARDIOLOGY Volume: 91 Page(s): 17C - 19C
  03/06/2003 Authors: Davidson MH; Wood DA; Paoletti R; Hobbs R; Shepherd J; Brown WV; Hunninghake DB; McKenney JM
• Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease.
  Am J Cardiol Volume: 91 Page(s): 575 - 580
  03/01/2003 Authors: Sprecher DL; Watkins TR; Behar S; Brown WV; Rubins HB; Schaefer EJ
• Relationship of peripheral arterial compliance and standard cardiovascular risk factors.
  Vasc Endovascular Surg Volume: 37 Page(s): 197 - 206
  01/01/2003 Authors: Willens HJ; Davis W; Herrington DM; Wade K; Kesler K; Mallon S; Brown WV; Reiber JHC; Raines JK
• Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
  Am Heart J Volume: 144 Page(s): 1036 - 1043
  12/01/2002 Authors: Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E; Rosuvastatin Study Group
• Promising therapies for cholesterol reduction.
  Manag Care Volume: 11 Page(s): 10 - 14
  09/01/2002 Authors: Brown WV
• CETP and LCAT contribute to formation of small dense LDL in vitro
  ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Volume: 22 Page(s): A73 - A73
  05/01/2002 Authors: Huey PU; Li XZ; Patel H; Sweeney ME; Davis W; Brown WV; Le NA
• Biomarkers of atherosclerotic disease in asymptomatic individuals identified by calcium score
  Volume: 22 Page(s): A61 - A61
  05/01/2002 Authors: Le NA; Arad Y; Huey P; Ngai N; Guerci AD; Brown WV
• Long-term efficacy and safety of rosuvastatin: results of a 52-week comparator-controlled trial versus pravastatin and simvastatin
  Volume: 22 Page(s): 270 - 270
  09/01/2001 Authors: Brown WV; Chitra RR; Zedler BK; Bays HE; Hassman HA
• Preventive strategies for reducing coronary heart disease-related morbidity and mortality in patients with multiple risk factors.
  J Am Osteopath Assoc Volume: 101 Page(s): S6 - 11
  09/01/2001 Authors: Brown WV
• What are the priorities for managing cholesterol effectively?
  Am J Cardiol Volume: 88 Page(s): 21F - 24F
  08/16/2001 Authors: Brown WV
• Therapies on the horizon for cholesterol reduction.
  Clin Cardiol Volume: 24 Page(s): III24 - III27
  08/01/2001 Authors: Brown WV
• Statin therapy in the new millennium: is there room for improvement?
  Clin Cardiol Volume: 24 Page(s): III1 - III2
  08/01/2001 Authors: Brown WV
• New therapies on the horizon.
  Am J Manag Care Volume: 7 Page(s): S148 - S151
  05/01/2001 Authors: Brown WV
• Novel approaches to lipid lowering: what is on the horizon?
  Am J Cardiol Volume: 87 Page(s): 23B - 27B
  03/08/2001 Authors: Brown WV
• Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl".
  Curr Control Trials Cardiovasc Med Volume: 2 Page(s): 12 - 15
  01/01/2001 Authors: Brown WV
• Risk factors for vascular disease in patients with diabetes.
  Diabetes Obes Metab Volume: 2 Suppl 2 Page(s): S11 - S18
  11/01/2000 Authors: Brown WV
• Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium.
  Metabolism Volume: 49 Page(s): 1271 - 1277
  10/01/2000 Authors: Le NA; Li X; Kyung S; Brown WV
• The benefit of aggressive lipid lowering.
  Volume: 1 Page(s): 15 - 19
  09/01/2000 Authors: Brown WV
• Cholesterol lowering in atherosclerosis.
  Am J Cardiol Volume: 86 Page(s): 29H - 32H
  08/24/2000 Authors: Brown WV
• Can aggressive lipid-lowering therapy provide additional clinical benefit? Subgroup analysis of the Atorvastatin VErsus Revascularization Treatments (AVERT) trial
  Volume: 21 Page(s): 157 - 157
  08/01/2000 Authors: Brown WV
• Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.
  Am J Clin Nutr Volume: 71 Page(s): 1433 - 1438
  06/01/2000 Authors: Anderson JW; Davidson MH; Blonde L; Brown WV; Howard WJ; Ginsberg H; Allgood LD; Weingand KW
• Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
  Metabolism Volume: 49 Page(s): 167 - 177
  02/01/2000 Authors: Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
• Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease - Reply
  NEW ENGLAND JOURNAL OF MEDICINE Volume: 341 Page(s): 1854 - 1855
  12/09/1999 Authors: Pitt B; Waters D; Brown WV
• Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
  N Engl J Med Volume: 341 Page(s): 1853 - 1854
  12/09/1999 Authors: Cohen DJ; Carrozza JP; Baim DS
• Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
  J Lipid Res Volume: 40 Page(s): 1875 - 1882
  10/01/1999 Authors: Breyer ED; Le NA; Li X; Martinson D; Brown WV
• Plasma exchange (TPE) for elevated lipoprotein(a) (Lp(a)) in a patient with xanthoma disseminatum (XD).
  TRANSFUSION Volume: 39 Page(s): 9S - 9S
  10/01/1999 Authors: Hill CE; Lankford KV; Brown WV; Duncan A; Hillyer CD
• Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
  N Engl J Med Volume: 341 Page(s): 70 - 76
  07/08/1999 Authors: Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
• An efficient chromatographic system for lipoprotein fractionation using whole plasma.
  J Lipid Res Volume: 39 Page(s): 679 - 690
  03/01/1998 Authors: Innis-Whitehouse W; Li X; Brown WV; Le NA
• Impact of dyslipidaemia. Lessons from clinical trials.
  Pharmacoeconomics Volume: 14 Suppl 3 Page(s): 1 - 9
  01/01/1998 Authors: Brown WV
• Landmark trials in lipid reduction.
  Volume: 1 Page(s): 110 - 114
  01/01/1998 Authors: Brown WV
• Cardiovascular disease and lipoproteins: available evidence and remaining questions. Reactor panel and open forum.
  Value Health Volume: 1 Page(s): 125 - 130
  01/01/1998 Authors: Schwartz JS; Brown WV; Hlatky M; Castelli W
• Protocol for the preparation of a segmental linear polyacrylamide gradient gel: simultaneous determination of Lp[a], LDL, and HDL particle sizes.
  J Lipid Res Volume: 38 Page(s): 2603 - 2614
  12/01/1997 Authors: Li X; Innis-Whitehouse W; Brown WV; Le NA
• Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT).
  Am J Cardiol Volume: 80 Page(s): 1130 - 1133
  11/01/1997 Authors: McCormick LS; Black DM; Waters D; Brown WV; Pitt B
• Basic demographic and professional characteristics of US women physicians.
  West J Med Volume: 166 Page(s): 179 - 184
  03/01/1997 Authors: Frank E; Rothenberg R; Brown WV; Maibach H
• Epidemiology and treatment of hypercholesterolemia: where we are today. Introduction.
  Am J Med Volume: 102 Page(s): 1 - 2
  02/17/1997 Authors: Brown WV
• Hypercholesterolemia in the United States: how far have we come?
  Am J Med Volume: 102 Page(s): 3 - 6
  02/17/1997 Authors: Brown WV
• Hyperlipidemia versus iron overload and coronary artery disease: yet more arguments on the cholesterol debate.
  J Clin Epidemiol Volume: 49 Page(s): 1353 - 1358
  12/01/1996 Authors: Weintraub WS; Wenger NK; Parthasarathy S; Brown WV
• Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
  JAMA Volume: 275 Page(s): 128 - 133
  01/10/1996 Authors: Bakker-Arkema RG; Davidson MH; Goldstein RJ; Davignon J; Isaacsohn JL; Weiss SR; Keilson LM; Brown WV; Miller VT; Shurzinske LJ
• Cold and warm myocardial protection techniques.
  Adv Card Surg Volume: 7 Page(s): 1 - 29
  01/01/1996 Authors: Guyton RA; Gott JP; Brown WM; Craver JM
• Niacin for lipid disorders. Indications, effectiveness, and safety.
  Postgrad Med Volume: 98 Page(s): 185 - 193
  08/01/1995 Authors: Brown WV
• Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.
  Diagn Microbiol Infect Dis Volume: 21 Page(s): 85 - 93
  02/01/1995 Authors: Jones RN; Sader HS; Erwin ME; Anderson SC
• Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
  N Engl J Med Volume: 331 Page(s): 1331 - 1337
  11/17/1994 Authors: Weintraub WS; Boccuzzi SJ; Klein JL; Kosinski AS; King SB; Ivanhoe R; Cedarholm JC; Stillabower ME; Talley JD; DeMaio SJ
• DOING THE RIGHT THING - STOP WORRYING ABOUT CHOLESTEROL - REPLY
  CIRCULATION Volume: 90 Page(s): 2573 - 2577
  11/01/1994 Authors: STAMLER J; STAMLER R; BROWN WV; GOTTO AM; GREENLAND P; GRUNDY S; HEGSTED DM; LUEPKER RV; NEATON JD; STEINBERG D
• Doing the right thing: stop worrying about cholesterol.
  Circulation Volume: 90 Page(s): 2572 - 2573
  11/01/1994 Authors: Ravnskov U
• Hydroxymethylglutaryl coenzyme a reductase inhibition: fluvastatin, a clinical investigators' update. Introduction.
  Am J Cardiol Volume: 73 Page(s): 1D - 2D
  05/26/1994 Authors: Brown WV
• Lipoprotein disorders in diabetes mellitus.
  Med Clin North Am Volume: 78 Page(s): 143 - 161
  01/01/1994 Authors: Brown WV
• Serum cholesterol. Doing the right thing.
  Circulation Volume: 88 Page(s): 1954 - 1960
  10/01/1993 Authors: Stamler J; Stamler R; Brown WV; Gotto AM; Greenland P; Grundy S; Hegsted DM; Luepker RV; Neaton JD; Steinberg D
• EFFECT OF WEIGHT-LOSS ON LDL PARTICLE-SIZE AND POSTPRANDIAL LIPEMIA IN OBESE SUBJECTS WITH CAD
  CIRCULATION Volume: 88 Page(s): 364 - 364
  10/01/1993 Authors: SWEENEY ME; LE NA; LI XZ; INNISWHITEHOUSE W; DAVIS L; UMEAKUNNE K; HALL WD; FLETCHER G; BROWN WV
• Lipids. Workshop IV. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health.
  Volume: 88 Page(s): 1397 - 1401
  09/01/1993 Authors: Pearson TA; Brown WV; Donato K; Franklin FA; Luepker RB; McBride PE; Mullis RM; Scott LW; Shannon B; Shekelle RB
• When do we treat hypercholesterolemia?
  Clin Cardiol Volume: 15 Page(s): III10 - III14
  11/01/1992 Authors: Brown WV
• When do we treat hypercholesterolemia?
  Clin Cardiol Volume: 15 Page(s): III10 - III14
  11/01/1992 Authors: Brown WV
• INDUCTION OF MCP-1 AND VCAM-1 EXPRESSION AND MONOCYTE INVASION IN AN INVITRO MODEL OF THE VESSEL WALL BY A POSTPRANDIAL SERUM FACTOR
  Volume: 86 Page(s): 333 - 333
  10/01/1992 Authors: HUBER AR; LE NA; INNIS W; BROWN WV; HARKER LA; ELLIS SE
• A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
  J Lipid Res Volume: 33 Page(s): 745 - 754
  05/01/1992 Authors: Ishimura-Oka K; Semenkovich CF; Faustinella F; Goldberg IJ; Shachter N; Smith LC; Coleman T; Hide WA; Brown WV; Oka K
• President's address to the 64th scientific sessions of the American Heart Association.
  Volume: 85 Page(s): 1969 - 1971
  05/01/1992 Authors: Brown WV
• Genetic lipoprotein abnormalities producing high blood cholesterol.
  Heart Dis Stroke Volume: 1 Page(s): 405 - 407
  01/01/1992 Authors: Brown WV; Breslow JL
• Lipoproteins: what, when, and how often to measure.
  Heart Dis Stroke Volume: 1 Page(s): 20 - 26
  01/01/1992 Authors: Brown WV
• Effect of acute intravenous alcohol on plasma lipoproteins in man.
  Metabolism Volume: 40 Page(s): 1128 - 1130
  11/01/1991 Authors: Mishra L; Le NA; Brown WV; Mezey E
• Molecular cloning of mouse hepatic triacylglycerol lipase: gene expression in combined lipase-deficient (cld/cld) mice.
  Biochim Biophys Acta Volume: 1089 Page(s): 13 - 20
  05/02/1991 Authors: Oka K; Nakano T; Tkalcevic GT; Scow RO; Brown WV
• Review of clinical trials: proving the lipid hypothesis.
  Volume: 11 Suppl H Page(s): 15 - 20
  12/01/1990 Authors: Brown WV
• Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.
  Atherosclerosis Volume: 85 Page(s): 81 - 89
  11/01/1990 Authors: Hunninghake DB; Knopp RH; Schonfeld G; Goldberg AC; Brown WV; Schaefer EJ; Margolis S; Dobs AS; Mellies MJ; Insull W
• Clinical trials including an update on the Helsinki Heart Study.
  Am J Cardiol Volume: 66 Page(s): 11A - 15A
  09/04/1990 Authors: Brown WV
• A SYMPOSIUM - THE SIGNIFICANCE OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN THE PREVENTION OF CORONARY-ARTERY DISEASE, PHOENIX, 9-10 SEPT 1989 - DISCUSSION
  AMERICAN JOURNAL OF CARDIOLOGY Volume: 66 Page(s): A28 - A31
  09/04/1990 Authors: BROWN WV; RIFKIND BM; SCHAEFER E; WILSON PWF; CANTER D; MILLER N; GOTTO AM
• Structure and polymorphic map of human lipoprotein lipase gene.
  Biochim Biophys Acta Volume: 1049 Page(s): 21 - 26
  05/24/1990 Authors: Oka K; Tkalcevic GT; Nakano T; Tucker H; Ishimura-Oka K; Brown WV
• A simple semi-dry capillary transfer of DNA.
  Biotechniques Volume: 8 Page(s): 173 - 174
  02/01/1990 Authors: Nakano T; Tucker H; Oka K; Brown WV
• Dietary recommendations to prevent coronary heart disease.
  Ann N Y Acad Sci Volume: 598 Page(s): 376 - 388
  01/01/1990 Authors: Brown WV
• Treatment of lipoprotein disorders.
  Cardiovasc Clin Volume: 20 Page(s): 157 - 176
  01/01/1990 Authors: Brown WV; Howard WJ
• AHA Conference Report on Cholesterol. Basis for dietary treatment.
  Circulation Volume: 80 Page(s): 729 - 734
  09/01/1989 Authors: Grundy SM; Brown WV; Dietschy JM; Ginsberg H; Goodnight S; Howard B; La Rosa JC; McGill HC
• Nucleotide sequence of PvuII polymorphic site at the human lipoprotein lipase gene locus.
  Nucleic Acids Res Volume: 17 Page(s): 6752
  08/25/1989 Authors: Oka K; Tkalcevic GT; Stocks J; Galton DJ; Brown WV
• Expression of lipoprotein lipase gene in combined lipase deficiency.
  Biochim Biophys Acta Volume: 1008 Page(s): 351 - 354
  08/14/1989 Authors: Oka K; Yuan JG; Senda M; Masibay AS; Qasba PK; Masuno H; Scow RO; Paterniti JR; Brown WV
• Interaction of lipoprotein lipase with heparin.
  Ann N Y Acad Sci Volume: 556 Page(s): 173 - 180
  01/01/1989 Authors: Oka K; Wang-Iverson P; Paterniti JR; Brown WV
• Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs.
  Cardiology Volume: 76 Suppl 1 Page(s): 45 - 51
  01/01/1989 Authors: Brown WV
• Treatment of hypercholesterolaemia with fenofibrate: a review.
  Curr Med Res Opin Volume: 11 Page(s): 321 - 330
  01/01/1989 Authors: Brown WV
• Effect of lipoprotein lipase and hepatic triglyceride lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins.
  Atherosclerosis Volume: 73 Page(s): 45 - 55
  09/01/1988 Authors: Gibson JC; Brown WV
• The cholesterol hypothesis and the value of intervention.
  J Am Osteopath Assoc Volume: 88 Page(s): 859 - 864
  07/01/1988 Authors: Brown WV
• Focus on fenofibrate.
  Hosp Pract (Off Ed) Volume: 23 Suppl 1 Page(s): 31 - 40
  06/01/1988 Authors: Brown WV
• Potential use of fenofibrate and other fibric acid derivatives in the clinic.
  Am J Med Volume: 83 Page(s): 85 - 89
  11/27/1987 Authors: Brown WV
• Fenofibrate, a third-generation fibric acid derivative.
  Am J Med Volume: 83 Page(s): 1 - 2
  11/27/1987 Authors: Brown WV
• Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia.
  Am J Med Volume: 83 Page(s): 50 - 59
  11/27/1987 Authors: Knopp RH; Brown WV; Dujovne CA; Farquhar JW; Feldman EB; Goldberg AC; Grundy SM; Lasser NL; Mellies MJ; Palmer RH
• Treating hyperlipidemia, Part III: Drug therapy.
  Geriatrics Volume: 42 Page(s): 55 - 62
  08/01/1987 Authors: Smith DA; Karmally W; Brown WV
• Treating hyperlipidemia, Part II: Making dietary control work in the elderly.
  Geriatrics Volume: 42 Page(s): 39 - 43
  07/01/1987 Authors: Smith DA; Karmally W; Brown WV
• Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase.
  Proc Natl Acad Sci U S A Volume: 84 Page(s): 4369 - 4373
  07/01/1987 Authors: Senda M; Oka K; Brown WV; Qasba PK; Furuichi Y
• Treating hyperlipidemia, Part I: Whether and when in the elderly.
  Geriatrics Volume: 42 Page(s): 33 - 44
  06/01/1987 Authors: Smith DA; Karmally W; Brown WV
• Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.
  Arteriosclerosis Volume: 7 Page(s): 401 - 407
  01/01/1987 Authors: Gibson JC; Goldberg RB; Rubinstein A; Ginsberg HN; Brown WV; Baker S; Joffe BI; Seftel HC
• In vitro metabolism of apolipoprotein E.
  Biochim Biophys Acta Volume: 879 Page(s): 355 - 361
  12/05/1986 Authors: Rubinstein A; Gibson JC; Ginsberg HN; Brown WV
• Evidence for heterogeneity of low-density lipoprotein metabolism in the cynomolgus monkey.
  Biochim Biophys Acta Volume: 879 Page(s): 179 - 185
  11/14/1986 Authors: Goldberg IJ; Le NA; Leeman B; Brown WV; Lindgren FT
• Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver.
  Lab Invest Volume: 55 Page(s): 347 - 362
  09/01/1986 Authors: Blanchette-Mackie EJ; Wetzel MG; Chernick SS; Paterniti JR; Brown WV; Scow RO
• Electrocardiographic abnormalities in diabetes mellitus: association between T-wave changes and nephropathy.
  Mt Sinai J Med Volume: 53 Page(s): 254 - 259
  04/01/1986 Authors: Faierman D; Bloomgarden ZT; Nechemias C; Brown WV
• Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.
  Arteriosclerosis Volume: 6 Page(s): 670 - 678
  01/01/1986 Authors: Brown WV; Dujovne CA; Farquhar JW; Feldman EB; Grundy SM; Knopp RH; Lasser NL; Mellies MJ; Palmer RH; Samuel P
• Kinetic analysis using specific radioactivity data.
  Methods Enzymol Volume: 129 Page(s): 384 - 395
  01/01/1986 Authors: Le NA; Ramakrishnan R; Dell RB; Ginsberg HN; Brown WV
• Isolation of apolipoprotein E-containing lipoproteins by immunoaffinity chromatography.
  Methods Enzymol Volume: 129 Page(s): 186 - 198
  01/01/1986 Authors: Gibson JC; Rubinstein A; Ginsberg HN; Brown WV
• Medical complications of isotretinoin.
  Clin Dermatol Volume: 4 Page(s): 183 - 189
  01/01/1986 Authors: Ginsberg H; Rubenstein A; Brown WV
• Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography.
  Methods Enzymol Volume: 129 Page(s): 457 - 469
  01/01/1986 Authors: Le NA; Bukberg PR; Ginsberg HN; Gibson JC; Brown WV
• Coronary risk factor statement for the American public. A statement of the nutrition committee.
  Circulation Volume: 72 Page(s): 1135A - 1139A
  11/01/1985 Authors: Grundy SM; Arky R; Bray GA; Brown WV; Ernst ND; Kwiterovich PO; Mattson F; Weidman WH; Schonfeld G; Strong JP
• Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency.
  Metabolism Volume: 34 Page(s): 832 - 835
  09/01/1985 Authors: Goldberg IJ; Mazlen RG; Rubenstein A; Gibson JC; Paterniti JR; Lindgren FT; Brown WV
• Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.
  J Lipid Res Volume: 26 Page(s): 1047 - 1057
  09/01/1985 Authors: Bukberg PR; Le NA; Ginsberg HN; Gibson JC; Rubinstein A; Brown WV
• Immunoaffinity isolation of apolipoprotein E-containing lipoproteins.
  Biochim Biophys Acta Volume: 835 Page(s): 113 - 123
  06/14/1985 Authors: Gibson JC; Rubinstein A; Ngai N; Ginsberg HN; Le NA; Gordon RE; Goldberg IJ; Brown WV
• Coronary heart disease and the consumption of diets high in wheat and other grains.
  Am J Clin Nutr Volume: 41 Page(s): 1163 - 1171
  05/01/1985 Authors: Brown WV; Karmally W
• Plasma apolipoprotein secretion by human monocyte-derived macrophages.
  Biochim Biophys Acta Volume: 834 Page(s): 256 - 262
  04/25/1985 Authors: Wang-Iverson P; Gibson JC; Brown WV
• Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized.
  J Biol Chem Volume: 260 Page(s): 2552 - 2557
  02/25/1985 Authors: Olivecrona T; Chernick SS; Bengtsson-Olivecrona G; Paterniti JR; Brown WV; Scow RO
• Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor.
  Biochem Biophys Res Commun Volume: 126 Page(s): 578 - 586
  01/16/1985 Authors: Wang-Iverson P; Ginsberg HN; Peteanu LA; Le NA; Brown WV
• Apo E-containing lipoproteins in low or high density lipoprotein deficiency.
  Arteriosclerosis Volume: 5 Page(s): 371 - 380
  01/01/1985 Authors: Gibson JC; Rubinstein A; Brown WV; Ginsberg HN; Greten H; Norum R; Kayden H
• Protocol for efficient plasma sampling for low density lipoprotein turnover studies.
  J Lipid Res Volume: 25 Page(s): 1387 - 1391
  12/01/1984 Authors: Le NA; Ginsberg HN; Brown WV
• Precipitation of apo E-containing lipoproteins by precipitation reagents for apolipoprotein B.
  Clin Chem Volume: 30 Page(s): 1784 - 1788
  11/01/1984 Authors: Gibson JC; Rubinstein A; Brown WV
• Elevated hemoglobin A1c and low-density lipoprotein cholesterol levels in thiazide-treated diabetic patients.
  Am J Med Volume: 77 Page(s): 823 - 827
  11/01/1984 Authors: Bloomgarden ZT; Ginsberg-Fellner F; Rayfield EJ; Bookman J; Brown WV
• Diet and the decrease of coronary heart disease.
  Am J Cardiol Volume: 54 Page(s): 27C - 29C
  08/27/1984 Authors: Brown WV; Ginsberg H; Karmally W
• Treatment of common lipoprotein disorders.
  Prog Cardiovasc Dis Volume: 27 Page(s): 1 - 20
  01/01/1984 Authors: Brown WV; Goldberg IJ; Ginsberg HN
• Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography.
  J Lipid Res Volume: 24 Page(s): 1251 - 1260
  09/01/1983 Authors: Bukberg PR; Le NA; Ginsberg HN; Gibson JC; Goldman LC; Brown WV
• Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse.
  Science Volume: 221 Page(s): 167 - 169
  07/08/1983 Authors: Paterniti JR; Brown WV; Ginsberg HN; Artzt K
• Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects.
  J Lipid Res Volume: 24 Page(s): 886 - 898
  07/01/1983 Authors: Gibson JC; Rubinstein A; Bukberg PR; Brown WV
• Measurement of lipoprotein lipase and hepatic triacylglycerol lipase in post-heparin plasma of the cynomolgus monkey.
  Biochim Biophys Acta Volume: 752 Page(s): 172 - 177
  06/16/1983 Authors: Goldberg IJ; Paterniti JR; Brown WV
• THE CULINARY HEARTS KITCHEN
  Volume: 32 Page(s): A120 - A120
  01/01/1983 Authors: BROWN WV; AUSTIN A
• Increased catabolism of native and cyclohexanedione-modified low density lipoprotein in subjects with myeloproliferative diseases.
  Arteriosclerosis Volume: 3 Page(s): 233 - 241
  01/01/1983 Authors: Ginsberg H; Goldberg IJ; Wang-Iverson P; Gitler E; Le NA; Gilbert HS; Brown WV
• Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting.
  Biochim Biophys Acta Volume: 712 Page(s): 250 - 257
  08/18/1982 Authors: Ginsberg H; Davidson N; Le NA; Gibson J; Ahrens EH; Brown WV
• Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee.
  Circulation Volume: 65 Page(s): 839A - 854A
  04/01/1982 Authors: Grundy SM; Bilheimer D; Blackburn H; Brown WV; Kwiterovich PO; Mattson F; Schonfeld G; Weidman WH
• Human monocytes in culture synthesize and secrete lipoprotein lipase.
  Biochem Biophys Res Commun Volume: 104 Page(s): 923 - 928
  02/11/1982 Authors: Wang-Iverson P; Ungar A; Bliumis J; Bukberg PR; Gibson JC; Brown WV
• Interaction of lipoprotein lipase with cultured endothelial cells.
  Ann N Y Acad Sci Volume: 401 Page(s): 92 - 101
  01/01/1982 Authors: Wang-Iverson P; Brown WV
• Lipoproteins as risk factors for vascular disease in diabetes.
  Mt Sinai J Med Volume: 49 Page(s): 176 - 186
  01/01/1982 Authors: Brown WV; Bloomgarden Z; Ginsberg H
• Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity.
  Am J Med Volume: 71 Page(s): 595 - 602
  10/01/1981 Authors: Gilbert HS; Ginsberg H; Fagerstrom R; Brown WV
• Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man.
  Am J Physiol Volume: 241 Page(s): E57 - E63
  07/01/1981 Authors: Turner JD; Le NA; Brown WV
• Effect of a high carbohydrate diet on apoprotein-B catabolism in man.
  Metabolism Volume: 30 Page(s): 347 - 353
  04/01/1981 Authors: Ginsberg HN; Le NA; Melish J; Steinberg D; Brown WV
• Lipoprotein metabolism in nonresponders to increased dietary cholesterol.
  Arteriosclerosis Volume: 1 Page(s): 463 - 470
  01/01/1981 Authors: Ginsberg H; Le NA; Mays C; Gibson J; Brown WV
• Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.
  Am J Physiol Volume: 239 Page(s): E354 - E362
  11/01/1980 Authors: Melish J; Le NA; Ginsberg H; Steinberg D; Brown WV
• Structure and metabolism of plasma lipoproteins---an overview.
  Nutr Metab Volume: 24 Suppl 1 Page(s): 1 - 2
  01/01/1980 Authors: Brown W
• Heart disease risk factors and hormone use in postmenopausal women.
  JAMA Volume: 241 Page(s): 2167 - 2169
  05/18/1979 Authors: Barrett-Connor E; Brown WV; Turner J; Austin M; Criqui MH
• A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase.
  J Lipid Res Volume: 20 Page(s): 548 - 556
  05/01/1979 Authors: Baginsky ML; Brown WV
• Hepatic triglyceride and lipoprotein lipase activities of post-heparin plasma in normals and hypertriglyceridemics.
  Ups J Med Sci Volume: 84 Page(s): 215 - 227
  01/01/1979 Authors: Boberg J; Boberg M; Gross R; Turner JD; Augustin J; Brown WV
• Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins.
  J Lipid Res Volume: 19 Page(s): 578 - 584
  07/01/1978 Authors: Le NA; Melish JS; Roach BC; Ginsberg HN; Brown WV
• A comparison of molecular properties of hepatic triglyceride lipase and lipoprotein lipase from human post-heparin plasma.
  J Biol Chem Volume: 253 Page(s): 2912 - 2920
  05/10/1978 Authors: Augustin J; Freeze H; Tejada P; Brown WV
• Quantitative determination of hepatic and lipoprotein lipase activities from human postheparin plasma.
  J Lipid Res Volume: 18 Page(s): 544 - 547
  07/01/1977 Authors: Boberg J; Augustin J; Baginsky ML; Tejada P; Brown WV
• Differential characteristics of purified hepatic triglyceride lipase and lipoprotein lipase from human postheparin plasma.
  J Lipid Res Volume: 18 Page(s): 423 - 437
  07/01/1977 Authors: Baginsky ML; Brown WV
• Characterization of two triacylglycerol lipase activities in pig post-heparin plasma.
  Biochem J Volume: 163 Page(s): 347 - 355
  05/01/1977 Authors: Ehnholm C; Bensadoun A; Brown WV
• The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
  Pediatrics Volume: 59 Page(s): 513 - 525
  04/01/1977 Authors: Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
• LOW-DENSITY LIPOPROTEIN (LDL) AND STEROL-METABOLISM IN AN UNUSUAL CASE OF FAMILIAL HYPOBETALIPOPROTEINEMIA
  Volume: 56 Page(s): 4 - 4
  01/01/1977 Authors: STEINBERG D; GRUNDY SM; MOK HYI; TURNER JD; WEINSTEIN DB; BROWN WV; ALBERS JJ
• Studies of the lipid binding characteristics of the apolipoproteins from human high density lipoprotein. II. Calorimetry of the binding of apo AI and apo AII with phospholipids.
  Biochim Biophys Acta Volume: 441 Page(s): 68 - 80
  07/20/1976 Authors: Rosseneu M; Soetewey F; Middelhoff G; Peeters H; Brown WV
• Study of the lipid binding characteristics of the apolipoproteins from human high density lipoprotein. I. Electron microscopic and gel filtration studies with synthetic phosphatidylcholines.
  Biochim Biophys Acta Volume: 441 Page(s): 57 - 67
  07/20/1976 Authors: Middelhoff G; Rosseneu M; Peeters H; Brown WV
• Effects of monoolein on hydrolysis of triglyceride by lipoprotein lipase in the presence of an inhibitory apolipoprotein.
  Physiol Chem Phys Volume: 8 Page(s): 197 - 206
  01/01/1976 Authors: Baginsky ML; Brown WV
• Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids.
  J Biol Chem Volume: 250 Page(s): 6756 - 6761
  09/10/1975 Authors: Ehnholm C; Shaw W; Greten H; Brown WV
• Incorporation of sialic acid into sialidase-treated apolipoprotein of human, very low density lipoprotein by a pork liver sialytransferase.
  Can J Biochem Volume: 52 Page(s): 654 - 664
  08/01/1974 Authors: Wetmore S; Mahley RW; Brown WV; Schachter H
• Familial homozygous hypobetalipoproteinemia.
  Metabolism Volume: 23 Page(s): 779 - 791
  08/01/1974 Authors: Cottrill C; Glueck CJ; Leuba V; Millett F; Puppione D; Brown WV
• A comparative study of post-heparin lipolytic activity and a purified human plasma triacylglycerol lipase.
  Biochim Biophys Acta Volume: 360 Page(s): 68 - 77
  07/26/1974 Authors: Ehnholm C; Greten H; Brown WV
• Evidence for the hepatic origin of a canine post-heparin plasma triglyceride lipase.
  FEBS Lett Volume: 42 Page(s): 157 - 160
  06/01/1974 Authors: Sniderman AD; Chandler JG; Steinberg D; Brown WV
• Purification and characterization of lipoprotein lipase from pig adipose tissue.
  J Biol Chem Volume: 249 Page(s): 2220 - 2227
  04/10/1974 Authors: Bensadoun A; Ehnholm C; Steinberg D; Brown WV
• Some functional aspects of apolipoproteins: apoLp-Ala inhibition of lipoprotein lipase and deinhibition by monoolein.
  Horm Metab Res Volume: Suppl 4 Page(s): 11 - 16
  01/01/1974 Authors: Brown WV; Baginsky ML
• Type I hyperlipoproteinaemia.
  Clin Endocrinol Metab Volume: 2 Page(s): 73 - 80
  03/01/1973 Authors: Brown WV; Greten H
• Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.
  J Clin Invest Volume: 51 Page(s): 1486 - 1494
  06/01/1972 Authors: Gotto AM; Brown WV; Levy RI; Birnbaumer ME; Fredrickson DS
• Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein.
  Biochem Biophys Res Commun Volume: 46 Page(s): 375 - 382
  01/31/1972 Authors: Brown WV; Baginsky ML
• Some functional aspects of the plasma apolipoproteins.
  Verh Dtsch Ges Inn Med Volume: 78 Page(s): 1292
  01/01/1972 Authors: Brown WV
• Changes in high-density lipoprotein protein composition after heparin-induced lipolysis.
  Am J Physiol Volume: 220 Page(s): 785 - 791
  03/01/1971 Authors: LaRosa JC; Levy RI; Brown WV; Fredrickson DS
• Further characterization of apolipoproteins from the human plasma very low density lipoproteins.
  J Biol Chem Volume: 245 Page(s): 6588 - 6594
  12/25/1970 Authors: Brown WV; Levy RI; Fredrickson DS
• Further characterization of the apolipoproteins of rat plasma lipoproteins.
  Biochemistry Volume: 9 Page(s): 3427 - 3433
  08/18/1970 Authors: Bersot TP; Brown WV; Levy RI; Windmueller HG; Fredrickson DS; LeQuire VS
• Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus.
  Science Volume: 168 Page(s): 380 - 382
  04/17/1970 Authors: Mahley RW; Bersot TP; LeQuire VS; Levy RI; Windmueller HG; Brown WV
• Studies of the proteins in human plasma very low density lipoproteins.
  J Biol Chem Volume: 244 Page(s): 5687 - 5694
  10/25/1969 Authors: Brown WV; Levy RI; Fredrickson DS
• Treatment of hypertriglyceridaemia.
  Lancet Volume: 2 Page(s): 852
  10/18/1969 Authors: Glueck CJ; Brown WV; Greten H; Levy RI; Fredrickson DS
• Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia.
  Lancet Volume: 1 Page(s): 1290 - 1291
  06/28/1969 Authors: Glueck CJ; Brown WV; Levy RI; Greten H; Fredrickson DS
• Clofibrate-induced ventricular arrhythmia.
  Am J Cardiol Volume: 23 Page(s): 266 - 269
  02/01/1969 Authors: La Rosa JC; Brown WV; Frommer PL; Levy RI